Traveler's Diarrhea Clinical Trial
Official title:
A Phase Two, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of the Travelers' Diarrhea Vaccine System in Travelers to Asia
The purpose of this study is to evaluate the efficacy of the TD Vaccine System to prevent moderate to severe enterotoxin E.coli (ETEC) disease in travelers to India.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00672035 -
Prevention, Randomized, Double-Blinded, Placebo-Controlled, Parallel Assignment, Safety/Efficacy Study
|
Phase 2 | |
| Completed |
NCT01208922 -
Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea
|
Phase 3 | |
| Completed |
NCT01142089 -
Study to Evaluate Safety and Efficacy of Rifamycin SV Multi-Matrix System (MMX) for the Treatment of Traveler's Diarrhea (TD)
|
Phase 3 | |
| Not yet recruiting |
NCT04026984 -
Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children Age 6 to 11 Years
|
Phase 2 | |
| Not yet recruiting |
NCT04027894 -
Study to Evaluate Safety and Efficacy of Rifamycin SV MMX in Treating Traveler's Diarrhea in Children Age 12 to 17 Years
|
Phase 2 | |
| Completed |
NCT03866291 -
ESBL in Patients Returning to Sweden With Traveller's Diarrhoea
|
||
| Completed |
NCT03301103 -
PTM202 and Modulation of Host Resistance to Diarrheagenic E. Coli
|
N/A | |
| Withdrawn |
NCT02736539 -
Clinical Trial of CBS-2004 in Prevention of Travelers' Diarrhea
|
Phase 3 |